Could a high Trig/HDL ratio indicate insulin resistance?

A high triglyceride to HDL cholesterol ratio (above 3.5) is a strong indicator of insulin resistance and metabolic dysfunction. This ratio reflects how well your body processes fats and sugars, with higher values suggesting increased risk for diabetes and heart disease.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Trig/HDL Ratio and Its Connection to Insulin Resistance

The triglyceride to HDL cholesterol ratio has emerged as one of the most reliable indicators of insulin resistance that can be measured through a simple blood test. This ratio provides valuable insights into your metabolic health by revealing how efficiently your body processes both fats and sugars. When insulin resistance develops, it affects not just glucose metabolism but also how your body handles lipids, creating a characteristic pattern in your cholesterol profile.

Insulin resistance occurs when your cells become less responsive to insulin's signals, requiring your pancreas to produce more insulin to maintain normal blood sugar levels. This metabolic dysfunction doesn't just affect glucose - it fundamentally alters how your body processes and stores fat. The result is often elevated triglycerides and reduced HDL cholesterol, creating an unfavorable ratio that serves as a red flag for metabolic problems.

Research has consistently shown that the Trig/HDL ratio correlates strongly with direct measures of insulin resistance, such as the hyperinsulinemic-euglycemic clamp test. In fact, some studies suggest this simple ratio can be as effective as more complex insulin resistance calculations like HOMA-IR, making it an accessible screening tool for metabolic health assessment.

Trig/HDL Ratio Interpretation Guide

These ranges apply to most populations but may vary based on ethnicity and individual factors. Consult with your healthcare provider for personalized interpretation.
Ratio RangeInterpretationHealth ImplicationsRecommended Actions
Below 2.0< 2.0OptimalGood insulin sensitivity, low cardiovascular riskMaintain healthy lifestyle, annual monitoring
2.0-3.52.0-3.5BorderlineEmerging insulin resistance, moderate riskLifestyle modifications, monitor every 6 months
Above 3.5> 3.5High RiskSignificant insulin resistance, high cardiovascular riskAggressive lifestyle changes, consider medical evaluation
Above 5.0> 5.0Very High RiskSevere metabolic dysfunction, very high disease riskImmediate medical consultation, comprehensive intervention

These ranges apply to most populations but may vary based on ethnicity and individual factors. Consult with your healthcare provider for personalized interpretation.

What Your Trig/HDL Ratio Numbers Mean

Understanding your Trig/HDL ratio requires knowing both your triglyceride and HDL cholesterol levels. To calculate the ratio, simply divide your triglyceride level by your HDL level. For example, if your triglycerides are 150 mg/dL and your HDL is 50 mg/dL, your ratio would be 3.0. The interpretation of this ratio varies slightly based on ethnicity and individual factors, but general guidelines provide useful benchmarks.

For most populations, a Trig/HDL ratio below 2.0 is considered optimal, indicating good insulin sensitivity and metabolic health. Ratios between 2.0 and 3.5 suggest emerging insulin resistance, while values above 3.5 indicate significant insulin resistance and increased cardiovascular risk. Some research suggests that in certain ethnic groups, particularly those of African descent, slightly different cutoffs may apply due to genetic variations in lipid metabolism.

It's important to note that this ratio should be interpreted alongside other metabolic markers. A single elevated reading doesn't definitively diagnose insulin resistance, but persistent elevation warrants further investigation. Regular monitoring of your lipid profile can help track changes over time and assess the effectiveness of lifestyle interventions.

The Science Behind the Connection

How Insulin Resistance Affects Lipid Metabolism

When insulin resistance develops, it triggers a cascade of metabolic changes that directly impact your lipid profile. In a healthy metabolism, insulin helps regulate the production and clearance of triglycerides while supporting HDL cholesterol production. However, when cells become resistant to insulin, this delicate balance is disrupted.

In insulin-resistant states, the liver increases its production of very-low-density lipoprotein (VLDL) particles, which are rich in triglycerides. Simultaneously, the enzyme lipoprotein lipase, which normally helps clear triglycerides from the bloodstream, becomes less effective. This dual effect leads to elevated triglyceride levels. Meanwhile, the same metabolic dysfunction reduces the production of HDL cholesterol and accelerates its clearance from the bloodstream.

The Role of Visceral Fat

Visceral adipose tissue, or belly fat, plays a crucial role in the relationship between the Trig/HDL ratio and insulin resistance. This metabolically active fat releases free fatty acids directly into the portal circulation, overwhelming the liver and contributing to both insulin resistance and dyslipidemia. The accumulation of visceral fat creates a self-perpetuating cycle where insulin resistance promotes further fat storage, which in turn worsens metabolic dysfunction.

Beyond Insulin Resistance: Other Health Implications

While the Trig/HDL ratio is an excellent marker for insulin resistance, its implications extend far beyond glucose metabolism. This ratio has been associated with numerous health conditions and can serve as a predictor for various metabolic and cardiovascular outcomes.

Cardiovascular Disease Risk

A high Trig/HDL ratio is strongly associated with increased cardiovascular disease risk. This relationship exists because the ratio reflects the presence of small, dense LDL particles - a particularly atherogenic form of cholesterol that easily penetrates arterial walls. Studies have shown that individuals with a Trig/HDL ratio above 3.5 have a significantly higher risk of coronary artery disease, even when their total cholesterol levels appear normal.

Metabolic Syndrome and Type 2 Diabetes

The Trig/HDL ratio is often elevated years before the development of type 2 diabetes, making it a valuable early warning sign. Research indicates that individuals with a ratio above 3.0 are at increased risk for developing metabolic syndrome, a cluster of conditions including high blood pressure, excess abdominal fat, and abnormal cholesterol levels. This ratio can help identify those who would benefit most from preventive interventions.

Non-Alcoholic Fatty Liver Disease (NAFLD)

The Trig/HDL ratio has also emerged as a useful marker for non-alcoholic fatty liver disease, a condition closely linked to insulin resistance. Studies have found that individuals with NAFLD typically have significantly higher Trig/HDL ratios compared to those with healthy livers. This association makes sense given that both conditions share common underlying metabolic dysfunction.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Factors That Influence Your Trig/HDL Ratio

Multiple factors can affect your Trig/HDL ratio, and understanding these influences is crucial for developing an effective improvement strategy. While some factors are modifiable through lifestyle changes, others may require medical intervention or are influenced by genetics.

  • Diet composition, particularly intake of refined carbohydrates and added sugars
  • Physical activity levels and exercise patterns
  • Body weight and fat distribution, especially visceral adiposity
  • Alcohol consumption, which can significantly elevate triglycerides
  • Certain medications, including beta-blockers and thiazide diuretics
  • Genetic factors that influence lipid metabolism
  • Hormonal status, including thyroid function and sex hormones
  • Sleep quality and duration
  • Chronic stress and cortisol levels

Testing and Monitoring Your Ratio

Calculating your Trig/HDL ratio requires a standard lipid panel, which measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. For the most accurate results, you should fast for 9-12 hours before the blood draw, as triglyceride levels can be significantly affected by recent food intake. Some newer testing methods allow for non-fasting measurements, but fasting values remain the gold standard for assessing metabolic health.

The frequency of testing depends on your current health status and risk factors. If your ratio is optimal (below 2.0), annual testing may be sufficient. However, if your ratio is elevated or you're actively working to improve it through lifestyle changes, more frequent monitoring every 3-6 months can help track your progress and adjust your approach as needed. Regular testing allows you to see how your body responds to different interventions and helps maintain motivation for healthy lifestyle changes.

When interpreting your results, it's important to look at trends over time rather than focusing on a single measurement. Triglyceride levels, in particular, can vary significantly from day to day based on diet, stress, and other factors. Tracking your ratio over multiple tests provides a more accurate picture of your metabolic health and helps identify whether your interventions are working effectively.

Strategies to Improve Your Trig/HDL Ratio

Dietary Modifications

Diet plays a crucial role in managing your Trig/HDL ratio. The most effective dietary approach typically involves reducing refined carbohydrates and added sugars while increasing healthy fats and fiber. Studies have shown that low-carbohydrate diets can dramatically improve the Trig/HDL ratio, often within weeks of implementation. Focus on whole foods, including non-starchy vegetables, lean proteins, nuts, seeds, and fatty fish rich in omega-3 fatty acids.

Specific dietary strategies that have proven effective include following a Mediterranean-style diet, incorporating intermittent fasting, and ensuring adequate protein intake at each meal. Avoiding sugary beverages, including fruit juices, can have a particularly powerful impact on triglyceride levels. Some individuals may benefit from working with a registered dietitian to develop a personalized nutrition plan that addresses their specific metabolic needs.

Exercise and Physical Activity

Regular physical activity is one of the most effective ways to improve insulin sensitivity and optimize your Trig/HDL ratio. Both aerobic exercise and resistance training have been shown to reduce triglycerides and increase HDL cholesterol. High-intensity interval training (HIIT) may be particularly effective for improving metabolic health markers in a time-efficient manner.

Aim for at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of vigorous activity per week, combined with two or more days of resistance training. Even modest increases in daily movement, such as taking regular walking breaks or using a standing desk, can contribute to improved metabolic health. The key is consistency - regular moderate exercise is more beneficial than sporadic intense workouts.

Lifestyle Factors

Beyond diet and exercise, several lifestyle factors significantly impact your Trig/HDL ratio. Prioritizing sleep quality and aiming for 7-9 hours per night can improve insulin sensitivity and lipid metabolism. Managing stress through techniques like meditation, yoga, or deep breathing exercises can help regulate cortisol levels, which influence both glucose and lipid metabolism.

If you consume alcohol, moderation is key, as excessive intake can dramatically increase triglyceride levels. Smoking cessation is also crucial, as tobacco use negatively affects HDL cholesterol levels and overall cardiovascular health. Weight loss, particularly reduction of visceral fat, can lead to significant improvements in the Trig/HDL ratio, with even modest weight loss of 5-10% of body weight showing measurable benefits.

When to Seek Medical Intervention

While lifestyle modifications are the first-line approach for improving your Trig/HDL ratio, some situations warrant medical evaluation and potential pharmaceutical intervention. If your ratio remains elevated despite consistent lifestyle changes, or if you have additional risk factors for cardiovascular disease or diabetes, consulting with a healthcare provider is essential.

Your doctor may recommend additional testing to assess insulin resistance more directly, such as fasting insulin levels, oral glucose tolerance tests, or hemoglobin A1c. In some cases, medications such as metformin for insulin resistance, statins for cholesterol management, or fibrates for triglyceride reduction may be appropriate. However, these should complement, not replace, healthy lifestyle habits.

Regular monitoring and follow-up are crucial when addressing metabolic health concerns. Your healthcare provider can help you set realistic goals, track your progress, and adjust your treatment plan as needed. Remember that improving metabolic health is typically a gradual process, and sustainable changes are more valuable than rapid but temporary improvements.

The Path Forward: Taking Control of Your Metabolic Health

Understanding your Trig/HDL ratio provides valuable insight into your metabolic health and risk for insulin resistance. This simple calculation from a standard lipid panel can serve as an early warning system, potentially identifying metabolic dysfunction years before the development of type 2 diabetes or cardiovascular disease. By monitoring this ratio and taking proactive steps to improve it, you can significantly impact your long-term health outcomes.

The good news is that the Trig/HDL ratio is highly responsive to lifestyle interventions. Through dietary modifications, regular physical activity, stress management, and other healthy habits, most people can achieve significant improvements in their ratio and overall metabolic health. The key is to start with sustainable changes and build momentum over time, celebrating small victories along the way.

Remember that metabolic health exists on a spectrum, and even small improvements in your Trig/HDL ratio can translate to meaningful health benefits. Whether you're looking to prevent future health problems or actively working to reverse insulin resistance, understanding and optimizing your Trig/HDL ratio is a powerful tool in your health optimization toolkit. Regular monitoring, combined with evidence-based lifestyle interventions, can help you achieve and maintain optimal metabolic health for years to come.

References

  1. McLaughlin, T., Reaven, G., Abbasi, F., et al. (2005). Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? American Journal of Cardiology, 96(3), 399-404.[PubMed][DOI]
  2. Giannini, C., Santoro, N., Caprio, S., et al. (2011). The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care, 34(8), 1869-1874.[PubMed][DOI]
  3. Salazar, M. R., Carbajal, H. A., Espeche, W. G., et al. (2012). Relation among the plasma triglyceride/high-density lipoprotein cholesterol ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. American Journal of Cardiology, 109(12), 1749-1753.[PubMed][DOI]
  4. Vega, G. L., Barlow, C. E., Grundy, S. M., et al. (2014). Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. Journal of Investigative Medicine, 62(2), 345-349.[PubMed][DOI]
  5. Ren, X., Chen, Z. A., Zheng, S., et al. (2016). Association between triglyceride to HDL-C ratio (TG/HDL-C) and insulin resistance in Chinese patients with newly diagnosed type 2 diabetes mellitus. PLoS One, 11(4), e0154345.[PubMed][DOI]
  6. Uruska, A., Zozulinska-Ziolkiewicz, D., Niedzwiecki, P., et al. (2015). TG/HDL-C ratio and visceral adiposity index may be useful in assessment of insulin resistance in adults with type 1 diabetes in clinical practice. Journal of Clinical Lipidology, 9(5), 664-670.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my triglycerides and HDL at home?

You can test your triglycerides and HDL cholesterol at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive lipid testing along with other cardiovascular and metabolic markers. The program provides regular testing to help you track your Trig/HDL ratio over time.

What is the ideal Trig/HDL ratio?

The ideal Trig/HDL ratio is below 2.0, which indicates good insulin sensitivity and metabolic health. Ratios between 2.0-3.5 suggest emerging insulin resistance, while values above 3.5 indicate significant insulin resistance and increased cardiovascular risk.

How quickly can I improve my Trig/HDL ratio?

With consistent dietary changes, particularly reducing refined carbohydrates and added sugars, many people see improvements in their Trig/HDL ratio within 4-8 weeks. Adding regular exercise can accelerate these improvements, though sustainable long-term changes are more important than rapid results.

Can medications affect my Trig/HDL ratio?

Yes, several medications can impact your ratio. Beta-blockers and thiazide diuretics may raise triglycerides, while statins can improve the ratio by lowering triglycerides and slightly raising HDL. Always discuss medication effects with your healthcare provider.

Is the Trig/HDL ratio accurate for all ethnicities?

While the Trig/HDL ratio is useful across populations, research suggests that cutoff values may vary by ethnicity. People of African descent may have different optimal ranges due to genetic variations in lipid metabolism. Discuss interpretation with your healthcare provider based on your individual background.

Should I be concerned if my ratio is high but my total cholesterol is normal?

Yes, a high Trig/HDL ratio is concerning even with normal total cholesterol. This pattern often indicates insulin resistance and increased cardiovascular risk that wouldn't be detected by looking at total cholesterol alone. It's important to address the underlying metabolic dysfunction.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details